Clinical research of non-invasive diagnostic assessment system in alcohol-related liver disease

Clinical research of non-invasive diagnostic assessment sysems in alcohol-related liver disease

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000034971

Enrollment

Unknown

Registered

2020-07-26

Start date

2020-09-01

Completion date

Unknown

Last updated

2020-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol-related liver disease

Interventions

Gold Standard:Clinical outcome: a history of long-term alcohol consumption over 5 years, ethanol consumption of >=40 g/day for men and >=20 g/day for women

or an evidence of binge drinking within 2 weeks, amounting to ethanol consumption of >80 g/day.

Index test:Serum&#32

biomarker&#32

and&#32

CT&#32

or&#32

MRI&#32

image&#32

data

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed as alcohol-related liver disease in our hospital from January 2020 to December 2023; 2. Patients with complete clinical information including image data and blood routine test, liver and kidney function test, coagulation function test, etc

Exclusion criteria

Exclusion criteria: 1. Patients who refused to consent to this study; 2. Patients with serious cardiovascular, lung, kidney, immune and cerebrovascular disease.

Design outcomes

Primary

Measure	Time frame
SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactYunwei Guo

Department of Gastroenterology, The Third Affiliated Hospital of Sun Yat-sen University

guoyw1973@hotmail.com+86 18922103958

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026